Regulation of the IgE response

F1000 Biology Reports

Volumn 2, Issue 1, 2010, Pages

  Conrad, Daniel H ^a   Gibb, David R ^a   Sturgill, Jamie ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; ADAM10 ENDOPEPTIDASE; APRIL PROTEIN; B CELL ACTIVATING FACTOR; CD134 ANTIGEN; CD23 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; FC EPSILON RECEPTOR I; FC RECEPTOR; GELATINASE B; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 21; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 4 RECEPTOR; LUMILIXIMAB; OMALIZUMAB; OX40 LIGAND; STAT3 PROTEIN; THYMIC STROMAL LYMPHOPOIETIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALLERGY; ASTHMA; CELL DIVISION; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG TARGETING; HELMINTH; HUMAN; HYPER IGE SYNDROME; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; PARASITE IMMUNITY; PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; TH2 CELL;

EID: 77955084933     PISSN: 17404118     EISSN: 1757594X     Source Type: Journal    
DOI: 10.3410/B2-14     Document Type: Review

References (37)

1. Carnes J, Robinson DS: New strategies for allergen immunotherapy. Recent Pat Inflamm Allergy Drug Discov 2008, 2:92-101.
2. Muramatsu M, Nagaoka H, Shinkura R, Begum NA, Honjo T: Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv Immunol 2007, 94:1-36.
3. Stavnezer J, Guikema JE, Schrader CE: Mechanism and regulation of class switch recombination. Annu Rev Immunol 2008, 26:261-92. (Pubitemid 351600377)
4. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T: Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-63.
5. Xu Z, Pone EJ, Al-Qahtani A, Park SR, Zan H, Casali P: Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit Rev Immunol 2007, 27:367-97.
6. Lougaris V, Badolato R, Ferrari S, Plebani A: Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev 2005, 203:48-66.
7. Hollingsworth JW, Whitehead GS, Lin KL, Nakano H, Gunn MD, Schwartz DA, Cook DN: TLR4 signaling attenuates ongoing allergic inflammation. J Immunol 2006, 176:5856-62.
8. Holgate ST, Davies DE: Rethinking the pathogenesis of asthma. Immunity 2009, 31:362-7.
9. Hasbold J, Lyons AB, Kehry MR, Hodgkin PD: Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. Eur J Immunol 1998, 28:1040-51.
10. Tangye SG, Ferguson A, Avery DT, Ma CS, Hodgkin PD: Isotype switching by human B cells is division-associated and regulated by cytokines. J Immunol 2002, 169:4298-306. (Pubitemid 35178202)
11. Caven TH, Shelburne A, Sato J, Chan-Li Y, Becker S, Conrad DH: IL-21 dependent IgE production in human and mouse in vitro culture systems is cell density and cell division dependent and is augmented by IL-10. Cell Immunol 2005, 238:123-34.
12. Avery DT, Ma CS, Bryant VL, Santner-Nanan B, Nanan R, Wong M, Fulcher DA, Cook MC, Tangye SG: STAT3 is required for IL-21-induced secretion of IgE from human naive B cells. Blood 2008, 112:1784-93.
13. Paulson ML, Freeman AF, Holland SM: Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3. Curr Opin Allergy Clin Immunol 2008, 8:527-33.
14. Pan G, French D, Mao W, Maruoka M, Risser P, Lee J, Foster J, Aggarwal S, Nicholes K, Guillet S, Schow P, Gurney AL: Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J Immunol 2001, 167:6559-67.
15. Barrett NA, Austen KF: Innate cells and T helper 2 cell immunity in airway inflammation. Immunity 2009, 31:425-37.
16. Coyle AJ, Lloyd C, Tian J, Nguyen T, Erikkson C, Wang L, Ottoson P, Persson P, Delaney T, Lehar S, Lin S, Poisson L, Meisel C, Kamradt T, Bjerke T, Levinson D, Gutierrez-Ramos JC: Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 1999, 190:895-902.
17. Seshasayee D, Lee WP, Zhou M, Shu J, Suto E, Zhang J, Diehl L, Austin CD, Meng YG, Tan M, Bullens SL, Seeber S, Fuentes ME, Labrijn AF, Graus YM, Miller LA, Schelegle ES, Hyde DM, Wu LC, Hymowitz SG, Martin F: In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation. J Clin Invest 2007, 117:3868-78.
18. Huang Y, Jin N, Roark CL, Aydintug MK, Wands JM, Huang H, O'Brien RL, Born WK: The influence of IgE-enhancing and IgE-suppressive gammadelta T cells changes with exposure to inhaled ovalbumin. J Immunol 2009, 183:849-55.
19. Wang YH, Angkasekwinai P, Lu N, Voo KS, Arima K, Hanabuchi S, Hippe A, Corrigan CJ, Dong C, Homey B, Yao Z, Ying S, Huston DP, Liu YJ: IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007, 204:1837-47.
20. Kurowska-Stolarska M, Kewin P, Murphy G, Russo RC, Stolarski B, Garcia CC, Komai-Koma M, Pitman N, Li Y, Niedbala W, McKenzie AN, Teixeira MM, Liew FY, Xu D: IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol 2008, 181:4780-90.
21. Garman SC, Wurzburg BA, Tarchevskaya SS, Kinet JP, Jardetzky TS: Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha. Nature 2000, 406:259-66.
22. Prenner BM: Asthma 2008: targeting immunoglobulin E to achieve disease control. J Asthma 2008, 45:429-36.
23. Plosker GL, Keam SJ: Omalizumab: a review of its use in the treatment of allergic asthma. BioDrugs 2008, 22:189-204.
24. MacGlashan DW Jr: Endocytosis, recycling, and degradation of unoccupied FcepsilonRI in human basophils. J Leukoc Biol 2007, 82:1003-10.
25. Conrad DH, Ford JW, Sturgill JL, Gibb DR: CD23: an overlooked regulator of allergic disease. Curr Allergy Asthma Rep 2007, 7:331-7.
26. Yu P, Kosco-Vilbois M, Richards M, Köhler G, Lamers MC, Kohler G: Negative feedback regulation of IgE synthesis by murine CD23. Nature 1994, 369:753-6. (Pubitemid 24225366)
27. Payet ME, Woodward EC, Conrad DH: Humoral response suppression observed with CD23 transgenics. J Immunol 1999, 163:217-23.
28. Poole JA, Meng J, Reff M, Spellman MC, Rosenwasser LJ: Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects. J Allergy Clin Immunol 2005, 116:780-8.
29. Ford JW, Kilmon MA, Haas KM, Shelburne AE, Chan-Li Y, Conrad DH: In vivo murine CD23 destabilization enhances CD23 shedding and IgE synthesis. Cell Immunol 2006, 243:107-17.
30. McCloskey N, Hunt J, Beavil RL, Jutton MR, Grundy GJ, Girardi E, Fabiane SM, Fear DJ, Conrad DH, Sutton BJ, Gould HJ: Soluble CD23 monomers inhibit and oligomers stimulate IGE synthesis in human B cells. J Biol Chem 2007, 282:24083-91.
31. Weskamp G, Ford JW, Sturgill J, Martin S, Docherty AJ, Swendeman S, Broadway N, Hartmann D, Saftig P, Umland S, Sehara-Fujisawa A, Black RA, Ludwig A, Becherer JD, Conrad DH, Blobel CP: ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nat Immunol 2006, 7:1293-8.
32. Lemieux GA, Blumenkron F, Yeung N, Zhou P, Williams J, Grammer AC, Petrovich R, Lipsky PE, Moss ML, Werb Z: The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. J Biol Chem 2007, 282:14836-44.
33. Jackson L, Cady CT, Cambier JC: TLR4-mediated signaling induces MMP9-dependent cleavage of B cell surface CD23. J Immunol 2009, 183:2585-92.
34. McMillan SJ, Kearley J, Campbell JD, Zhu XW, Larbi KY, Shipley JM, Senior RM, Nourshargh S, Lloyd CM: Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol 2004, 172:2586-94.
35. Robinson DS: Regulatory T cells and asthma. Clin Exp Allergy 2009, 39:1314-23.
36. Pongratz G, McAlees JW, Conrad DH, Erbe RS, Haas KM, Sanders VM: The level of IgE produced by a B cell is regulated by norepinephrine in a p38. J Immunol 2006, 177:2926-38.
37. McAlees JW, Sanders VM: Hematopoietic protein tyrosine phosphatase mediates beta2-adrenergic receptor-induced regulation of p38 mitogen-activated protein kinase in B lymphocytes. Mol Cell Biol 2009, 29:675-86.